HANSA BIOPHARMA AB SK 1 financial statements, including revenue, expenses, profit, and loss

The total revenue of 24H for the last quarter is 4.85 M EUR, and it's 7.50% higher compared to the previous quarter. The net income of Q1 24 is -18.92 M EUR.